pubmed.ncbi.nlm.nih.gov

Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels - PubMed

Comment

. 2003 Mar;37(3):712-3; author reply 713.

doi: 10.1053/jhep.2003.50099.

Comment

Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels

Andreas Geier et al. Hepatology. 2003 Mar.

No abstract available

Chronic hepatitis B.
Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Lok AS, et al. Hepatology. 2001 Dec;34(6):1225-41. doi: 10.1053/jhep.2001.29401. Hepatology. 2001. PMID: 11732013 No abstract available.

Monitoring of HBe antigen and alanine aminotransferase levels in hepatitis B virus DNA positive patients.
Imtiaz F, Abbas Z, Moatter T. Imtiaz F, et al. J Coll Physicians Surg Pak. 2005 Feb;15(2):103-4. J Coll Physicians Surg Pak. 2005. PMID: 15730837 No abstract available.
Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
Dai CY, Chuang WL, Huang JF, Yu ML. Dai CY, et al. Hepatology. 2009 Feb;49(2):704-5; author reply 705-6. doi: 10.1002/hep.22723. Hepatology. 2009. PMID: 19177587 No abstract available.
A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
Zhao H, Miao R. Zhao H, et al. Hepatology. 2009 Aug;50(2):658; author reply 658-9. doi: 10.1002/hep.23110. Hepatology. 2009. PMID: 19585650 No abstract available.
Treatment of HBeAg-positive patients with nucleos/tide analogues.
Coffin CS, Lee SS. Coffin CS, et al. Liver Int. 2009 Jan;29 Suppl 1:116-24. doi: 10.1111/j.1478-3231.2008.01935.x. Liver Int. 2009. PMID: 19207974 Review.
Clinical trial results and treatment resistance with lamivudine in hepatitis B.
Wright TL. Wright TL. Semin Liver Dis. 2004;24 Suppl 1:31-6. doi: 10.1055/s-2004-828676. Semin Liver Dis. 2004. PMID: 15192799 Review.